|
WO2015196068A2
|
|
Loss of dyrk1b gene function to inhibit metabolic syndrome including diabetes and hypertension
|
|
US2015073829A1
|
|
Method and system for distributing patient data and patient status notifications
|
|
AU2011229984A1
|
|
Diagnostic device for determining mechanical integrity of bone
|
|
WO2010033825A2
|
|
Genetic variants associated with abdominal aortic aneurysms
|
|
WO2009145831A1
|
|
Treatment of the idiopathic nephrotic syndrome spectrum diseases using basiliximab
|
|
CA2718708A1
|
|
Genetic indicators of weight loss
|
|
US2011046602A1
|
|
Devices and methods for fluid administration
|
|
WO2008134748A1
|
|
Screentop microplate lid and assembly
|
|
US2010212063A1
|
|
Medical modesty garment
|
|
US2009304704A1
|
|
Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash)
|
|
WO2007095353A2
|
|
Gpcrs as angiogenesis targets
|
|
EP1836315A2
|
|
Zebrafish heterotrimer g-protein gamma 2 subunit (gng2)
|
|
AU2002360768A1
|
|
Proteomic analysis of tumors for development of consultative report of therapeutic options
|
